HALEON PLC (HLN)

London
Currency in GBP
411.60
+0.10(+0.02%)
Closed·
HLN Scorecard
Full Analysis
Management has been aggressively buying back shares
HLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
409.10415.30
52 wk Range
319.84417.70
Key Statistics
Edit
Bid/Ask
375.00 / 420.00
Prev. Close
411.5
Open
412.6
Day's Range
409.1-415.3
52 wk Range
319.84-417.7
Volume
24.93M
Average Volume (3m)
27.45M
1-Year Change
25.14%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HLN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
412.18
Upside
+0.14%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

HALEON Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Employees
24561

Compare HLN to Peers and Sector

Metrics to compare
HLN
Peers
Sector
Relationship
P/E Ratio
25.7x8.5x−0.4x
PEG Ratio
0.660.020.00
Price/Book
2.3x1.5x2.6x
Price / LTM Sales
3.3x1.9x2.9x
Upside (Analyst Target)
2.0%29.9%51.7%
Fair Value Upside
Unlock23.8%9.5%Unlock

Analyst Ratings

9 Buy
8 Hold
1 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 412.18
(+0.14% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.16%
Dividend Yield
1.60%
Industry Median 2.53%
Annualised payout
6.60
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
0.0507 / --
Revenue / Forecast
2.85B / 2.87B
EPS Revisions
Last 90 days

People Also Watch

2,076.00
HIK
-0.10%
8,594.0
IHG
-0.81%
2,691.00
CPG
+0.04%
961.8
BRBY
-1.54%
212.50
PFD
+0.24%

FAQ

What Is the HALEON (HLN) Stock Price Today?

The HALEON stock price today is 411.60

What Stock Exchange Does HALEON Trade On?

HALEON is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for HALEON?

The stock symbol for HALEON is "HLN."

Does HALEON Pay Dividends? What’s The Current Dividend Yield?

The HALEON dividend yield is 1.6%.

What Is the HALEON Market Cap?

As of today, HALEON market cap is 37.07B.

What Is HALEON's Earnings Per Share (TTM)?

The HALEON EPS (TTM) is 0.16.

When Is the Next HALEON Earnings Date?

HALEON will release its next earnings report on 30 Jul 2025.

From a Technical Analysis Perspective, Is HLN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has HALEON Stock Split?

HALEON has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.